We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.13B
AUM Growth
-$2.03B
Cap. Flow
+$382B
Cap. Flow %
4,191.08%
Top 10 Hldgs %
16.25%
Holding
592
New
147
Increased
69
Reduced
127
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Industrials 17.44%
3 Financials 11.93%
4 Healthcare 11.85%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXIM
551
DELISTED
Maxim Integrated Products
MXIM
-51,836
Closed -$3.04M
FLIR
552
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
-618,482
Closed -$32.1M
MIK
553
DELISTED
Michaels Stores, Inc
MIK
-1,161,898
Closed -$22.3M
PS
554
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-100,000
Closed -$2.44M
NBRV
555
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-880
Closed -$765K
AIMT
556
DELISTED
Aimmune Therapeutics
AIMT
-173,591
Closed -$4.67M
NBL
557
DELISTED
Noble Energy, Inc.
NBL
-451,409
Closed -$15.9M
FSCT
558
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
-25,000
Closed -$857K
FTSI
559
DELISTED
FTS International, Inc. Common Stock
FTSI
-13,700
Closed -$3.9M
NTGN
560
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
-125,000
Closed -$1.57M
TSG
561
DELISTED
The Stars Group Inc.
TSG
-225,000
Closed -$8.17M
FTSV
562
DELISTED
Forty Seven, Inc. Common Stock
FTSV
-100,000
Closed -$1.6M
DERM
563
DELISTED
Dermira, Inc.
DERM
-103,465
Closed -$952K
CRZO
564
DELISTED
Carrizo Oil & Gas Inc
CRZO
-359,000
Closed -$10M
SNNA
565
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
-27,730
Closed -$421K
NRCG
566
DELISTED
NRC Group Holdings Corp.
NRCG
-300,000
Closed -$3.04M
ALDR
567
DELISTED
Alder Biopharmaceuticals
ALDR
-114,528
Closed -$1.81M
YOGA
568
DELISTED
YogaWorks, Inc. Common Stock
YOGA
-42,275
Closed -$76K
PETX
569
DELISTED
Aratana Therapeutics, Inc.
PETX
-137,345
Closed -$584K
GNCA
570
DELISTED
Genocea Biosciences, Inc.
GNCA
-200,386
Closed -$1.06M
WFT
571
DELISTED
Weatherford International plc
WFT
-8,235,484
Closed -$27.1M
CMTA
572
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
-225,862
Closed -$2.97M
LOXO
573
DELISTED
Loxo Oncology, Inc
LOXO
-53,302
Closed -$9.25M
NFX
574
DELISTED
Newfield Exploration
NFX
-1,421,743
Closed -$43M
PF
575
DELISTED
Pinnacle Foods, Inc.
PF
-210,252
Closed -$13.7M

Similar funds

Alyeska Investment Group's Q3 2018 Portfolio in Review

As of Q3 2018, Alyeska Investment Group held 592 positions worth $9.13B, down 18% from $11.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $382B of net new capital in Q3 2018, opening 147 new positions and adding to 69 existing holdings. Its largest new stake was Marvell Technology: 6,576,490 shares worth $127M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $144M trimmed.

  • Alyeska Investment Group's largest Q3 2018 buy was Marvell Technology: 6,576,490 shares worth $127M.
  • Alyeska Investment Group added most to Electronic Arts in Q3 2018, an estimated $185M increase.
  • Alyeska Investment Group's biggest Q3 2018 reduction was Palo Alto Networks, cutting an estimated $144M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q3 2018, selling an estimated $201M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $9.13B portfolio in Q3 2018.
  • Alyeska Investment Group opened 147 new positions and closed 192 in Q3 2018.
  • Alyeska Investment Group's portfolio value fell 18% quarter-over-quarter to $9.13B.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.